SG11201702165WA - Salt of phenylglycine methyl ester - Google Patents
Salt of phenylglycine methyl esterInfo
- Publication number
- SG11201702165WA SG11201702165WA SG11201702165WA SG11201702165WA SG11201702165WA SG 11201702165W A SG11201702165W A SG 11201702165WA SG 11201702165W A SG11201702165W A SG 11201702165WA SG 11201702165W A SG11201702165W A SG 11201702165WA SG 11201702165W A SG11201702165W A SG 11201702165WA
- Authority
- SG
- Singapore
- Prior art keywords
- salt
- methyl ester
- phenylglycine methyl
- phenylglycine
- ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/36—Racemisation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
- C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
- C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
- C07D499/68—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with aromatic rings as additional substituents on the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/04—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by acylation of the substituent in the 7 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/06—Cephalosporin C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
- C12P37/04—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin by acylation of the substituent in the 6 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01011—Penicillin amidase (3.5.1.11), i.e. penicillin-amidohydrolase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14185735 | 2014-09-22 | ||
PCT/EP2015/071324 WO2016046055A1 (en) | 2014-09-22 | 2015-09-17 | Salt of phenylglycine methyl ester |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201702165WA true SG11201702165WA (en) | 2017-04-27 |
Family
ID=51582299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201702165WA SG11201702165WA (en) | 2014-09-22 | 2015-09-17 | Salt of phenylglycine methyl ester |
Country Status (12)
Country | Link |
---|---|
US (1) | US20170298406A1 (he) |
EP (1) | EP3197863A1 (he) |
JP (1) | JP2017528495A (he) |
KR (1) | KR20170058941A (he) |
CN (1) | CN107074742A (he) |
AU (1) | AU2015321062A1 (he) |
BR (1) | BR112017005618A2 (he) |
CA (1) | CA2961698A1 (he) |
IL (1) | IL251099A0 (he) |
MX (1) | MX2017003498A (he) |
SG (1) | SG11201702165WA (he) |
WO (1) | WO2016046055A1 (he) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111909046A (zh) * | 2020-08-27 | 2020-11-10 | 天津大学 | D-苯甘氨酸甲酯磷酸盐结晶及制备方法、溶液 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101277927A (zh) * | 2005-09-29 | 2008-10-01 | 帝斯曼知识产权资产管理有限公司 | 用于酯化有机酸的方法 |
CN101631872B (zh) * | 2007-03-09 | 2014-07-16 | 中化帝斯曼制药有限公司荷兰公司 | 制备β-内酰胺化合物的工艺 |
CN103805671B (zh) * | 2013-11-11 | 2015-08-26 | 华北制药河北华民药业有限责任公司 | 一种制备头孢氨苄的方法 |
CN103757085B (zh) * | 2013-11-28 | 2016-06-15 | 湖南福来格生物技术有限公司 | 头孢克洛及其合成方法 |
CN103805672B (zh) * | 2014-02-25 | 2016-05-25 | 华北制药集团先泰药业有限公司 | 一种酶法制备氨苄西林的工艺 |
-
2015
- 2015-09-17 BR BR112017005618A patent/BR112017005618A2/pt not_active Application Discontinuation
- 2015-09-17 CN CN201580050969.2A patent/CN107074742A/zh active Pending
- 2015-09-17 SG SG11201702165WA patent/SG11201702165WA/en unknown
- 2015-09-17 JP JP2017515829A patent/JP2017528495A/ja not_active Withdrawn
- 2015-09-17 CA CA2961698A patent/CA2961698A1/en not_active Abandoned
- 2015-09-17 KR KR1020177007692A patent/KR20170058941A/ko unknown
- 2015-09-17 MX MX2017003498A patent/MX2017003498A/es unknown
- 2015-09-17 EP EP15763365.2A patent/EP3197863A1/en not_active Withdrawn
- 2015-09-17 US US15/513,156 patent/US20170298406A1/en not_active Abandoned
- 2015-09-17 WO PCT/EP2015/071324 patent/WO2016046055A1/en active Application Filing
- 2015-09-17 AU AU2015321062A patent/AU2015321062A1/en not_active Abandoned
-
2017
- 2017-03-12 IL IL251099A patent/IL251099A0/he unknown
Also Published As
Publication number | Publication date |
---|---|
IL251099A0 (he) | 2017-04-30 |
US20170298406A1 (en) | 2017-10-19 |
JP2017528495A (ja) | 2017-09-28 |
CA2961698A1 (en) | 2016-03-31 |
WO2016046055A1 (en) | 2016-03-31 |
AU2015321062A1 (en) | 2017-03-30 |
CN107074742A (zh) | 2017-08-18 |
EP3197863A1 (en) | 2017-08-02 |
BR112017005618A2 (pt) | 2018-01-23 |
MX2017003498A (es) | 2017-09-19 |
KR20170058941A (ko) | 2017-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251584A0 (he) | דיהידרופירולופירידינים מעכבי ror-גמא | |
IL246902A0 (he) | דיהידרופירולופירידין מעכבי ror–גמא | |
IL250511A0 (he) | צורות גבישיות של איברוטיניב | |
IL246785A0 (he) | בנזאימידאזול–2–אמינים כמעכבי midh1 | |
IL252873A0 (he) | מלח ה-l טרטראט של פרידופידין | |
HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
PL3059223T3 (pl) | Wytwarzanie mieszanin estrów | |
SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
ZA201702756B (en) | Amphoteric ester sulfonates | |
IL246979A0 (he) | צורות גבישיות של סופוסבוביר | |
PL3143095T3 (pl) | Mieszanina soli | |
IL249130B (he) | הכנה של פיפרידין–4–קרבותיואמיד | |
IL251099A0 (he) | מלח של פנילגליצין מתיל אסטר | |
TWM490537U (en) | Structure of stand | |
PL3191099T3 (pl) | Pochodne pirydopirymidyn | |
IL249332A0 (he) | צורות גבישיות של סופוסבוביר | |
HK1208220A1 (en) | Synthesis method of 9-allylcamptothecin derivatives 9- | |
GB201418051D0 (en) | Intelligent point of sale apparatus | |
TH1601001738A (th) | วิธีการผลิตสารประกอบเอสเตอร์ | |
GB201416951D0 (en) | Method of synthesis | |
HUP1400294A2 (hu) | Clopidogrel új alkalmazása | |
GB201417348D0 (en) | Prodrugs of lxazomib | |
GB201417347D0 (en) | Prodrugs of delanzomib | |
PT3165222T (pt) | Utilização do composto de ftalida |